References
- Stone C. A., et al. J. Pharmacol. & exp. Ther.: 1964; vol. 144(2)
- Cairn-cross K. D., et al. J. Pharmacol & exp. Ter.: 1965; vol. 149: 365
- Charalampous K. D., et al. J. clin. Pharm. 1967
- Ayd F. J. Mind 1963; 11
- Dorfman W. Amer. J. Psychiat. 1963; vol. 120(6)
- Dorfman W. »Recent advances in psychopharmology«. 1963; vol. 24(11)
- Arnold O. H., Krypsin-Exner K. Wien. med. Wschr.: 1964; 114: 883
- Master R. S. Indian J. Psych. 1964; VI(3)
- Vaisberg M. »Diseases of the Nervous System«. 1964; 25: 110
- Catindig C. T., et al. J. Military Surg. 1964; III(2)
- Kline N. S., et al. Psychosomatica 1965; VI: 330
- Krakowski A. J. Amer. J. Psychiat.: 1965; 121: 807
- Brick H., et al. J. Neuropsychiat. 1965; 1: 325
- Straker M., et al. Canad. m. Ass. 1966; 94
- Daneman E. A. Psychosomatics: 1965; VI
- Bretns O., Heshe J. Ugeskr. Læg. 1967; 129(22)735
- Ambrozi L., et al. Klin. med. Heft. 1967; 3: 22
- Gilbert M. M. J. Neuropsychiatry 1967; 3: 36
- Oltman J. E., Friedman S. Amer. J. Psychiat. 1965; 122: 582–584